Pfizer going 'all in' on obesity drug development, CEO Bourla says
Go back to Pfizer going 'all in' on obesity drug development, CEO Bourla says| Pfizer Inc. (NYSE: PFE) | Delayed: 27.91 +0.12 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.77 | 52 Week Low | $28.25 | |||
| Day High | $27.91 | P/E | 16.92 | |||
| Day Low | $27.66 | EPS | $1.65 | |||
| Volume | 3,059,251 | |||||

